Changes to this Summary (02/20/2009)
The PDQ cancer information summaries are reviewed regularly and updated as
new information becomes available. This section describes the latest
changes made to this summary as of the date above.
General Information
Cited Möricke et al. as reference 27 and level of evidence 2Di.
Cellular Classification and Prognostic Variables
Cited Borowitz et al. as reference 134 and level of evidence 3iiDi.
Added text to state that for patients with high hyperdiploidy and unfavorable trisomies, higher levels of minimal residual disease at the end of induction therapy appear to be associated with higher risk of subsequent relapse.
Untreated Childhood Acute Lymphoblastic Leukemia
Cited Möricke et al. as reference 33 and level of evidence 2Di.
Childhood Acute Lymphoblastic Leukemia in Remission
Added text to state that some regimens extend maintenance therapy for boys based on the high risk of relapse (added Möricke et al. as reference 22 and level of evidence 2Di).
Back to Top
< Previous Section | Next Section > |